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Introduction: The European population is aging and the number of elderly patients suffering
from ischemic brain stroke increases. A better knowledge of the correlation between the risk
factors and the course of the disease in old people may be useful for planning medical care
and prophylactic strategies.
Aim: This prospective study aimed to perform a demographic and clinical analysis of the
etiology of ischemic stroke, survival rate and severity of post-stroke disability in patients
who developed ischemic stroke at the age of over 85 years in the Polish population.
Method: The study group consisted of 159 patients over 85 years old with ischemic stroke.
The prevalence of risk factors such as sex, hypertension, hyperlipidemia, atrial ﬁbrillation,
heart failure and diabetes was evaluated. The outcome was assessed using the Barthel scale
and the National Institutes of Health Stroke Scale.
Results: The most common risk factors of ischemic stroke were hypertension and atrial
ﬁbrillation. Patients with atrial ﬁbrillation had a more severe course of ischemic stroke.
Conclusion: The course of brain stroke in the Polish population is more severe in patients over
85 years old than in younger ones. The key risk factor in this group is atrial ﬁbrillation.
© 2017 Published by Elsevier Sp. z o.o. on behalf of Polish Neurological Society.
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The risk factors of ischemic stroke in people over 85 years old
are not well established. Particularly, because they can change* Corresponding author.
E-mail address: zpastuszak@imdik.pan.pl (Ż. Pastuszak).
https://doi.org/10.1016/j.pjnns.2017.11.007
0028-3843/© 2017 Published by Elsevier Sp. z o.o. on behalf of Polish Nover time and vary depending on the country. The European
population is getting older and, therefore, the problem is
becoming more serious [1,2]. The incidence of stroke increases
steeply with age and in the case of individuals over 80 years old
is approximately 27% compared with 13% for individuals 60–79eurological Society.
Table 1 – Comparison between NIHSS and Barthel scores
in the groups with ischemic stroke and ischemic stroke
with secondary hemorrhaging.
Score Type of
ischemic stroke
n m SD p
Initial NIHSS score No HT 150 11.32 7.16 0.025
HT 5 17.80 4.49
Final NIHSS score No HT 150 11.14 7.71 0.030
HT 5 17.80 4.49
Initial Barthel score No HT 151 5.84 7.75 0.190
HT 5 0.80 1.79
Final Barthel score No HT 151 6.16 8.27 0.252
HT 5 1.20 2.68
where n denotes the number of patients, data are shown as mean
value (M)  SD.
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is expected to increase even by as much as 40% [4]. According
to The National Health Fund report, cardiovascular system
diseases, including brain stroke, are the main reason for
hospitalization in Poland, constituting 44% of all hospital
admissions [5]. Moreover, almost 20% of women and 16% of
men will die due to brain stroke [6]. The etiology of stroke is
often unknown in very old patients. The difﬁculty to determine
the cause of the disease is connected with multiple organ
dysfunction, the presence of other neurological conditions, the
adverse side effects of pharmacotherapy and poor medical
care. Of the ischemic strokes with well-known etiology, the
most common cause was embolism of a large vessel due to
atrial ﬁbrillation and watershed infarction caused by hypo-
tension. The coexistence of cardiovascular disorders such as
atherosclerotic lesions, valvular defects, arrhythmias and
heart failure, is responsible for the increase of ischemic stroke
incidence with age [4,7].
The aim of this prospective study was to examine the
demographic characteristics and risk factors in individuals
over 85 years old in the Polish population. The present study is
a clinical analysis of the course of brain stroke in that age
group, the frequency of complications, the survival rate and
morbidity. A better knowledge of the correlation between the
risk factors and the course of the disease in that age group
may be useful for planning medical care and prophylactic
strategies.
2. Materials and method
The investigated group consisted of 159 ischemic stroke
patients, both males and females, treated in the Department
of Neurology of the Military Institute of Medicine in Warsaw
between 2010 and 2015. The age range of the patients was from
85 to 102 years (average age: 89  3 years). The occlusion of the
major brain artery (anterior or middle cerebral artery) was a
cause of stroke in 54% of the patients, 40% suffered a lacunar
type of stroke and 6% of the patients experienced stroke of the
brainstem or cerebellum. Thrombolytic treatment was intro-
duced in 5 patients (3.14%). In the present study, the risk
factors of brain strokes such as hypertension, atrial ﬁbrillation,
heart failure, diabetes and hyperlipidemia were evaluated. The
neurological status was assessed with the help of The National
Institutes of Health Stroke Scale (NIHSS) and the Barthel scale
on the ﬁrst and last day of hospitalization. Moreover, the
results of computer tomography (CT) examinations performed
during admission to the hospital and abnormalities in
ultrasonography of the carotid arteries (USG) were analyzed.
The effectiveness and safety of the anticoagulant and statin
treatment in the investigated group were also evaluated.
Finally, complications related to hospitalization and survival
rate were analyzed. Mann–Whitney U and Chi-squared tests
were used for statistical analysis of the data.
3. Results
Demographic analysis revealed that 76% of the patients
studied were women. Five out of 156 patients (3.14%) sufferedfrom ischemic stroke with spontaneous hemorrhagic trans-
formation (HT). The Mann–Whitney U test revealed that the
mean NIHSS score (both on admission and at discharge) was
statistically higher than in the group without HT (Table 1).
Hypertension was reported in the medical history in 66% of
the patients on admission to the Department of Neurology.
The two other important risk factors were: atrial ﬁbrillation
(AF) diagnosed before the occurrence of brain stroke (35%) and
congestive heart failure (35%). Diabetes was diagnosed in the
case of 24% of the patients. Further study revealed that 17% of
the patients underwent ischemic brain stroke in the past (15%
underwent brain stroke in the previous year and 56% earlier).
Moreover, 8% of the patients had transient ischemic attacks
(TIA) and 42% of them had those symptoms the previous year.
Additionally, 11% of the patients had ischemic heart disease,
3% underwent heart infraction, 6% had hyperlipidemia and 1%
had chronic renal failure. Interestingly, in the course of
hospitalization the percentage of patients diagnosed with
hyperlipidemia increased to 21%, an additional 4% was
diagnosed with hypertension and 1% with diabetes. Likewise,
due to previous poor diagnosis, the percentage of patients with
AF increased by an additional 18% and with congestive heart
failure by 11%. Therefore, AF, at 53%, became the second most
important risk factor in that group.
Ischemic foci were found in CT examinations carried out on
admission to the hospital in the case of 42% of the patients.
Carotid artery stenosis was detected in ultrasonography in the
case of 9% of the examined patients. In 8% of those patients,
the stenosis was symptomatic. There were no statistically
signiﬁcant differences in stroke severity (measured with the
NIHSS and Barthel scores) and in the lipid proﬁle between
patients with carotid artery stenosis and those with a normal
ultrasonography result.
The most frequent complications of hospitalization were
urinary tract infection (25%) and pneumonia (19%). Acute renal
failure was diagnosed in 7% of the patients and acute
respiratory insufﬁciency in 7% of the patients. Epileptic attacks
were experienced by 6% of the patients in the examined group.
Other complications were less frequent and included gastro-
intestinal hemorrhage and deep vein thrombosis (5%). Acute
heart failure was present in the case of 3% of the patients.
Table 2 – Mean values of the lipid profile.
n m SD Min Max
Total cholesterol [mg/dl] 132 178.70 51.63 33 381
LDL cholesterol [mg/dl] 125 111.20 46.86 19 300
HDL cholesterol [mg/dl] 126 52.52 75.85 8 886
Triglyceride level [mg/dl] 129 106.50 54.37 27 394
where n denotes the number of patients, data are shown as mean
value (M)  SD.
Table 4 – AF occurrence vs. the level of NIHSS and Barthel
scores for examined patients at discharge.
Score AF (atrial
ﬁbrillation)
N m SD p
NIHSS score
at discharge
Does not occur 76 9.99 7.86 0.024
Occurs 83 12.53 7.33
Barthel score
at discharge
Does not occur 76 7.39 8.52 0.038
Occurs 83 4.70 7.69
where n denotes the number of patients, data are shown as mean
value (M)  SD.
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in 2% of the patients.
Among the examined group, 26% of the patients had an
abnormal value of HDL cholesterol, 25% of the patients had an
abnormal value of total cholesterol, 22% had an abnormal LDL
cholesterol level and 13% had an abnormal level of triglyceride.
Mean values of the lipid proﬁle are presented in Table 2.
There were no differences between the lipid proﬁles in men
and women, with the exception of the HDL level. Analysis with
the use of the Chi-Squared test revealed that the difference in
the HDL level was statistically signiﬁcant and the HDL level
was more frequently lower in women than in men (p = 0.009).
Moreover, patients treated with statins (both with a normal
and abnormal lipid proﬁle) had a less severe course of disease
(higher Barthel score and lower NIHSS score) (Table 3).
Among patients without AF, abnormal values of the total
cholesterol and abnormal values of LDL cholesterol were the
most frequent disorders of the lipid proﬁle – constituting 30%
and 29% respectively. It was observed that 22% of the patients
without AF had abnormal values of HDL cholesterol, whereas
17% of the patients without AF had abnormal values of
triglycerides. Analysis with the Mann–Whitney U test did not
show statistically signiﬁcant changes in the lipid proﬁle
between women and men. This means that there was no
difference of the level of the lipid proﬁle values between
patients with AF (atrial ﬁbrillation) and patients without AF.
In the group of patients with atrial ﬁbrillation taking
anticoagulants on admission to the hospital, only 25% had a
therapeutic INR (between 2.0 and 3.0). In the case of patients
with atrial ﬁbrillation diagnosed before brain stroke, 75% had
paroxysmal AF and 25% had ﬁxed AF. Among them, only 28.5%
were treated orally with vitamin K antagonists (acenocumarol
or warfarin) and only 14% had therapeutic INR. Thirty-six and a
half percent of the patients with atrial ﬁbrillation were notTable 3 – Correlation between statin treatment and final
NIHSS and Barthel scores (Mann–Whitney U test).
Score Hypolipidemic
treatment
at discharge
n M SD p
Final NIHSS score No statins 128 12.09 7.63 0.003
Statins 29 7.62 6.81
Final Barthel score No statins 129 5.11 7.78 0.004
Statins 29 10.10 8.88
where n denotes the number of patients, data are shown as mean
value (M)  SD.treated with anticoagulants or antiplatelet drugs. In addition, 8
patients of this group stopped taking the medicine a few days
before the brain stroke due to bleeding (epistaxis, alimentary
and urinary tract bleeding). Thirty-ﬁve percent of the patients
were taking salicylic acid (ASA). There were no statistically
signiﬁcant differences of stroke severity and course between
patients who were given a therapeutic effective anticoagulant
treatment and patients who were taking anticoagulants and
had non-therapeutic INR, or were taking ASA, or were not
taking any drugs at all. The Mann–Whitney U test showed that
patients with brain stroke associated with atrial ﬁbrillation
had a statistically signiﬁcant higher NIHSS score and a
statistically signiﬁcant lower Barthel score at the end of
hospitalization when compared with those without AF
(Table 4).
Only 3.14% of the patients were given thrombolytic
treatment. There was no signiﬁcant difference between the
mean NIHSS score in the group of patients treated with
thrombolytic agents compared to the group without that
treatment (Table 5).
During the ﬁrst 30 days of hospitalization, 33% of the
patients with stroke died. According to the Mann–Whitney U
test, those who died had higher NIHSS score and a lower
Barthel score than the patients who survived 30 days of
hospitalization (Table 6).
There was no correlation between increased prevalence of
particular risk factors of ischemic brain stroke, sex and 30-day
survival rate.Table 5 – The application of thrombolytic treatment vs.
the level of NIHSS score of examined patients on
admission and at discharge.
Score Thrombolytic
treatment
n m SD p
NIHSS score on
admission
No thrombolytic
treatment
150 11.40 7.19 0.131
Thrombolytic
treatment
6 16.83 1.60
NIHSS score at
discharge
No thrombolytic
treatment
150 11.17 7.71 0.072
Thrombolytic
treatment
6 17.83 1.47
where n denotes the number of patients, data are shown as mean
value (M)  SD.
Table 6 – Mortality in the first 30 days and results of the
NIHSS and Barthel scores on admission.
Score 30-day
mortality
n m SD p
NIHSS score on
admission
No 107 9.62 6.97 <0.001
Yes 51 15.49 5.75
Barthel score on
admission
No 107 7.98 8.20 <0.001
Yes 52 0.87 2.63
where n denotes the number of patients, data are shown as mean
value (M)  SD.
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Older people have a higher risk of developing ischemic brain
stroke. After the age of 55 years, the risk of having an ischemic
stroke doubles every 10 years. By the age of 85 years, the
incidence is higher in men, whereas after the age of 85 years
women are more frequently affected by this stroke [4]. The
cumulated risk of ischemic brain stroke at the age of 85 years
old is close to 15% [8]. The increased incidence of brain stroke
in this age group is also related to poorer patient care [9]. The
most frequent risk factors for ischemic stroke regardless of age
are male sex, hypertension, hypercholesterolemia, diabetes,
cardiovascular disease, alcohol consumption and smoking
[10,11]. In the group of old people, the cardiovascular risk factor
proﬁle may be different and needs to be investigated. For
example, Arboix et al. reported that the most common risk
factors of ischemic brain strokes in the population over 85
years old were congestive heart failure, chronic nephropathy,
female sex, previous cerebral infarction and atrial ﬁbrillation
[1]. In the present study, the most common risk factor of brain
stroke was hypertension (66% of cases). There are no
consistent data in the literature on the importance rating of
arterial hypertension as a risk factor for stroke in people over
85 years of age [10,11,9]. However, a ﬁvefold increase in the risk
of stroke in the population of 70–75 years old with uncontrolled
arterial hypertension when compared with the same age
group without arterial hypertension has been demonstrated
[12,13]. Although hypertension was the most common risk
factor of ischemic stroke in our study, atrial ﬁbrillation seemed
to be the most relevant factor. It was diagnosed in more than
half of the patients in this study. Moreover, atrial ﬁbrillation
and hyperlipidemia were the most common risk factors
diagnosed during hospitalization. Taking into account asymp-
tomatic and undiagnosed AF, the estimated occurrence of this
disease in the general population amounts to 1.5–2% [14]. This
increases, however, with age. The results of the cohort studies
show that arrhythmia occurs in 0.7% of individuals in the age
range of 55–59 years and in 17.8% of individuals over 85 years
old. The frequency of AF is higher in men than in women [15].
The risk of stroke attributed to AF increases also with age,
rising from 1.5% in individuals in the age range of 50–59 years
to 23.5% in those who are 80–89 years old [7,16–18]. Due to the
increased occurrence of atrial ﬁbrillation in patients over 80
years old, it seems that this group could beneﬁt most from the
use of anticoagulants, although, the risk of hemorrhagic
complications related to taking these medicines also increaseswith age. When introducing such treatment in old patients,
the risk-beneﬁt balance should be taken into account and the
patient's health condition should be closely monitored. The
potential beneﬁt of anticoagulation in these patients should be
veriﬁed properly. When starting the treatment, it is necessary
to take into account the contraindications and the patient's
choice and to keep INR within the range of 2.0–3.0. Proper
control of INR in old patients can be extremely difﬁcult which
is conﬁrmed by our present study. In the studied group, 86% of
patients with AF taking anticoagulants had nontherapeutic
INR, stopped taking medicines a few days prior to the
occurrence of stroke or did not take medicines regularly.
Moreover, a high percentage of patients with atrial ﬁbrillation
were diagnosed ﬁrst during their hospitalization in the stroke
ward, thus indicating a need for close monitoring of those
patients for atrial ﬁbrillation through echocardiography and
Holter electrocardiography. Another study showed that non-
compliance with medical dispositions, the low level of
awareness and education of patients and lack of cooperation
between patients and medical personnel in all age groups
constitute the main reason for the failure of anticoagulative
treatment [18,19]. Atrial ﬁbrillation is the most common
cardiac source of embolic stroke but other cardiological risk
factors should not be forgotten such as myocardial infarction,
left ventricular thrombus, valve disease and prosthetic valves
[20]. Many people at old age have undiagnosed congestive
heart failure. In our study, according to their medical history,
35% of the patients suffered from chronic heart failure and 11%
of the patients were diagnosed with the disease during
hospitalization. Therefore, periodic cardiological control in
old patients is very important, including clinical evaluation
and echocardiographic control for heart failure. The determi-
nation of the appropriate time that should elapse from the
occurrence of stroke to the introduction of anticoagulative
treatment in patients with atrial ﬁbrillation is also problemat-
ic. The main concerns are related to the risk of hemorrhagic
conversion of the ischemic focus. In the present study, the
symptoms of the secondary hemorrhagic conversion of stroke
focus conﬁrmed by CT examination occurred in the case of 3%
of the patients. Taking into account the beneﬁts of such
treatment and the relatively low risk of hemorrhagic conver-
sion of stroke in this age group, the introduction of this
treatment during hospitalization should not be delayed.
There is a lack of information on the effectiveness and
safety of thrombolytic treatment in patients older than 85
years old. In the present study, only 5 patients were given that
treatment. No signiﬁcant improvement of neurological status
measured with the NIHSS was observed after the treatment.
Similar results concerning mortality were reported in another
study on 6 patients receiving thrombolytic therapy [21]. No
signiﬁcant long-term decrease of mortality was reported. The
functional outcomes at ﬁnal follow-up were not analyzed in
that study. The main concerns regarding the application of
thrombolysis in this group of patients are related to systemic
hemorrhagic complications and secondary hemorrhagic con-
version of the brain stroke. In the case of thrombolysis as well
as endarterectomy, age should not be the decisive factor for
disqualiﬁcation of patients from such treatment [21,22]. One of
the most important exclusion criteria for carotid endarterec-
tomy in symptomatic patients was residual life expectancy of
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10% of the patients over 85 years old were alive 5 years after the
onset of stroke [23,24]. However, further studies on larger
populations are needed to evaluate survival rate after stroke
and to establish more practical criteria of active intervention
for very old patients.
The course of disease is also different in people in that age
group and is determined by poorer cardiovascular response,
multiple organ dysfunction, multiple medication consump-
tion and the presence of other neurological conditions. With
increasing severity of the course of stroke, there are more
complications and more adverse events related to pharmaco-
therapy. In addition, there are more complications caused by a
bedridden state. According to some sources, early mortality in
stroke patients over 85 years old is twice as high as in younger
patients [4,25]. According to our present analysis, 33% of the
patients died during the ﬁrst 30 days of hospitalization.
Statistical analysis revealed the relationship between mortali-
ty and the NIHSS and Barthel scores on admission. In addition,
the course of disease was more severe in patients with atrial
ﬁbrillation-induced ischemic stroke and their NIHSS score was
higher when compared with patients without atrial ﬁbrilla-
tion. Additionally, the risk of complications resulting from
immobilization caused by brain stroke increases with age,
particularly the risk of respiratory failure, airways infection,
urinary tract infection and bedsores [25]. In our study,
respiratory and urinary tract infections were the most
common complications that occurred during hospitalization.
Several studies demonstrate a direct relationship between
cholesterol levels, triglyceride levels and cardiovascular
mortality [26,27]. Dyslipidemia is a deﬁnite risk factor of
ischemic heart disease but the relationship between choles-
terol and stroke appears to be more controversial and
inconsistent across studies [3,27]. The literature data are
contradictory. There are some studies which report no
signiﬁcant relationship between cholesterol levels and inci-
dence of stroke [28–30]. By contrast, in other studies, the
elevation of total cholesterol was associated with a 25%
increased risk of ischemic stroke [31,32]. According to a study
by Simons et al., only the LDL level predicted ischemic stroke in
an Australian population of elderly patients [33]. It was
suggested that this inconsistency was caused by the hetero-
geneity in the pathogenesis of ischemic stroke [31,34]. This
suggestion is reﬂected in prospective registries of stroke,
where dyslipidemia is described in up to 46% of atherothrom-
botic infarctions and up to 38% of lacunar infarctions, but in
less than 20% of cardioembolic infarctions [35,36]. In the
present study, 26% of the patients had an abnormal value of
HDL cholesterol, 25% of the patients had an abnormal value of
total cholesterol, 22% had abnormal LDL and 13% had
abnormal triglyceride. There were no differences between
the lipid proﬁle in men and women, except for the difference in
the HDL level which was statistically signiﬁcant and the HDL
level was frequently lower in women than in men. Patients
treated with statins (both with normal and abnormal lipid
proﬁle) had a less severe course of disease (higher Barthel
score and lower NIHSS score). In addition, no statistically
signiﬁcant difference between the values of the individual
fractions of lipid proﬁle in patients with stroke related to AF
and patients with stroke not related to AF was shown.5. Conclusion
Due to an aging population, the increase in the incidence of
ischemic brain stroke should be expected. Many issues related
to the treatment and prevention of cardiovascular disorders in
this age group require further research. Despite the fact that, in
general, recommendations referring to the treatment of the
acute phase of brain stroke are not different from those
corresponding to younger patients, it should be noted that this
age group has a different drug metabolism. In addition, this
age group is characterized by higher mortality and a more
severe course of brain stroke. Elderly patients require intensive
monitoring of their health condition in reference to brain
stroke risk factors, in particular, arterial hypertension and
atrial ﬁbrillation. The introduction of anticoagulant treatment
would require the enhanced control of the coagulation
parameters and the use of anticoagulant medicines. Poly-
pragmasy and hypotonia should be avoided. The issue related
to the assessment of the safety and effectiveness of throm-
bolytic treatment and endarterectomy, as well as the issue
concerning the application of new anticoagulants, such as
rivaroxaban and dabigatran, require further examination.
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